Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2026-05-24 @ 1:17 PM
Study NCT ID:
NCT02015520
Status:
COMPLETED
Last Update Posted:
2021-05-12
First Post:
2013-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis
Sponsor:
CSL Behring
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rheumatoid Arthritis | View |
Keywords: